Nahlah Makki Almansour

5PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 25, 2026
Targeting the ERK2 Signaling Pathway With Frog Skin-Derived Bioactive Peptides: Insights From Molecular Modeling, Molecular Dynamics, and Physicochemical Features.

|Sep 13, 2025
Computational Discovery of Selective Carbonic Anhydrase IX (CA IX) Inhibitors via Pharmacophore Modeling and Molecular Simulations for Cancer Therapy.

Nahlah Makki Almansour

|Dec 23, 2023
Role of Mangiferin in Management of Cancers through Modulation of Signal Transduction Pathways.

Arshad Husain Rahmani, Ahmad Almatroudi, Khaled S Allemailem

|Jan 21, 2023
In Silico Mining of Natural Products Atlas (NPAtlas) Database for Identifying Effective Bcl-2 Inhibitors: Molecular Docking, Molecular Dynamics, and Pharmacokinetics Characteristics.

Nahlah Makki Almansour, Khaled S Allemailem, Abeer Abas Abd El Aty

|Sep 19, 2022
In silico drug repurposing and lipid bilayer molecular dynamics puzzled out potential breast cancer resistance protein (BCRP/ABCG2) inhibitors.

Nahlah Makki Almansour, Alaa H M Abdelrahman, Ekram Ismail Fagiree

Pageof 1

Frequent Collaborators

3 joint publications

Mahmoud A A Ibrahim

2 joint publications

Khaled S Allemailem

1 joint publications

Alaa H M Abdelrahman

1 joint publications

Ekram Ismail Fagiree Ismail